Health · Pharma & Biotech · 1 hr ago
Five drugmakers say they will not start trials at some China sites
Five major drugmakers told a US House committee they would not start new clinical studies at sites linked to China’s military.
The companies are Merck, Eli Lilly, AbbVie, Pfizer and Bristol Myers Squibb.
They also said they would not open new trial sites in Xinjiang, a region of China.
The House Select Committee on China began investigating the companies last June over concerns about intellectual property, military links and ethical standards at trial sites.
The committee also raised concerns about possible security risks.
The companies’ commitments apply to new studies, not existing trials.
The committee’s investigation is ongoing, and the companies’ letters to it disclosed their plans.
Five drugmakers told a House committee they would not start new clinical studies at sites linked to China’s military.
The companies are Merck, Eli Lilly, AbbVie, Pfizer and Bristol Myers Squibb.
The disclosure came from the House Select Committee on China.
The committee had opened investigations into the companies over concerns including intellectual property exposure, military ties and ethical standards at trial sites.
The committee also cited rising concern about possible security risks.
- Who
- Merck, Eli Lilly, AbbVie, Pfizer and Bristol Myers Squibb.
- What
- They told a House committee they would not initiate new clinical studies at sites linked to the People’s Liberation Army.
- When
- The disclosure was reported on November 20, 2026. The committee opened its investigations the previous June.
- Where
- At clinical trial sites in China, including sites linked to the Chinese military.
- Why
- The committee cited concerns about intellectual property exposure, military entanglements, ethical standards and possible security risks.
This story does not have two clearly opposing sides.
The House Select Committee on China opened investigations into five drugmakers.
The committee disclosed that all five companies would not start new clinical studies at sites linked to the People’s Liberation Army.
- Drugmakers
- Merck, Eli Lilly, AbbVie, Pfizer and Bristol Myers Squibb
- Committee
- House Select Committee on China
- Trial sites
- Sites linked to the People’s Liberation Army
- Investigation opened
- June
- Disclosure reported
- November 20, 2026